NASDAQ:RZLT

Rezolute Shares Edge Higher Ahead of Key FDA Week
····

Rezolute Shares Edge Higher Ahead of Key FDA Week

Rezolute shares rose 4 cents to $3.30 in premarket Nasdaq trading Monday, ahead of the company’s appearance at the Jefferies Global Healthcare Conference. The FDA has not approved Rezolute’s main drug, ersodetug, after its Phase 3 trial in congenital hyperinsulinism missed its primary endpoint. Rezolute reported $120.3 million in cash at March’s end, down from $167.9 million in June 2025.
June 1, 2026

Stock Market Today

  • FTSE 100 dips 0.7% as Iran halts US peace talks; oil prices surge
    June 1, 2026, 1:19 PM EDT. The FTSE 100 fell 0.7% to 10,338.95 on Monday following Iran's suspension of peace talks with the U.S. amid renewed conflict linked to Israel's Lebanon offensive. The FTSE 250 and AIM also declined. Brent crude oil prices jumped to $97.22 a barrel, responding to Iran's threats to block key shipping routes including the Strait of Hormuz. European markets also slipped, with Paris' CAC 40 down 0.5% and Frankfurt's DAX 40 falling 0.4%. In contrast, U.S. indexes were mixed. UK manufacturing expanded at its fastest pace in four years despite cost pressures linked to Middle East tensions. BP and Shell shares rose over 2% on the back of higher oil prices. Key global currencies and Treasury yields reflected heightened geopolitical risk and market caution.